Effect of Losartan on Retinal Endothelial Function in Patients With Essential Hypertension.

Trial Profile

Effect of Losartan on Retinal Endothelial Function in Patients With Essential Hypertension.

Withdrawn prior to enrolment
Phase of Trial: Phase II/III

Latest Information Update: 05 Jul 2012

At a glance

  • Drugs Losartan; Metoprolol
  • Indications Essential hypertension
  • Focus Pharmacodynamics
  • Most Recent Events

    • 05 Jul 2012 Actual initiation date (Sep 2005), lead trial centre and investigator added as reported by ClinicalTrials.gov.
    • 05 Jul 2012 Actual end date (Jan 2006) added as reported by ClinicalTrials.gov.
    • 05 Jul 2012 Status changed from completed to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top